Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D000526:Alprenolol / Q000494:pharmacology; D001249:Asthma / Q000503:physiopathology; D001980:Bronchi / Q000187:drug effects; D001986:Bronchial Spasm / Q000139:chemically induced*; D006801:Humans; D007545:Isoproterenol / Q000009:adverse effects / Q000037:antagonists & inhibitors; D009130:Muscle, Smooth / Q000187:drug effects; D010096:Oxprenolol / Q000009:adverse effects; D010869:Pindolol / Q000627:therapeutic use; D011217:Practolol / Q000009:adverse effects; D011433:Propranolol / Q000009:adverse effects; D012119:Respiration / Q000187:drug effects*
D000319:Adrenergic beta-Antagonists; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D010869:Pindolol; D007545:Isoproterenol; D011217:Practolol